Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival.

Prince LR, Prosseda SD, Higgins K, Carlring J, Prestwich EC, Ogryzko NV, Rahman A, Basran A, Falciani F, Taylor P, Renshaw SA, Whyte MKB, Sabroe I.

Blood. 2017 Aug 24;130(8):1014-1025. doi: 10.1182/blood-2017-03-770164. Epub 2017 Jun 21.


Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.

Preciado-Llanes L, Wing JB, Foster RA, Carlring J, Lees A, Read RC, Heath AW.

Immunology. 2014 Sep 20. doi: 10.1111/imm.12389. [Epub ahead of print]


Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.

Wing JB, Smart L, Borrow R, Findlow J, Findlow H, Lees A, Foster RA, Carlring J, Read RC, Heath AW.

PLoS One. 2012;7(2):e31160. doi: 10.1371/journal.pone.0031160. Epub 2012 Feb 8. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/45ca0028-74a1-427d-ba95-3dbd2acc6b80. Foster, Rachel A [added] Carlring, Jennifer [added].


Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and antitumor effects in mice.

Carlring J, Szabo MJ, Dickinson R, De Leenheer E, Heath AW.

Blood. 2012 Mar 1;119(9):2056-65. doi: 10.1182/blood-2011-05-355461. Epub 2012 Jan 10.


A novel redox method for rapid production of functional bi-specific antibodies for use in early pilot studies.

Carlring J, De Leenheer E, Heath AW.

PLoS One. 2011;6(7):e22533. doi: 10.1371/journal.pone.0022533. Epub 2011 Jul 21.


CD154-CD40 interactions in the control of murine B cell hematopoiesis.

Carlring J, Altaher HM, Clark S, Chen X, Latimer SL, Jenner T, Buckle AM, Heath AW.

J Leukoc Biol. 2011 May;89(5):697-706. doi: 10.1189/jlb.0310179. Epub 2011 Feb 17.


Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.

Foster RA, Carlring J, Lees A, Borrow R, Ramsay M, Kacsmarski E, Miller E, McKendrick MW, Heath AW, Read RC.

Clin Vaccine Immunol. 2010 Jul;17(7):1104-10. doi: 10.1128/CVI.00481-09. Epub 2010 May 12.


CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxis.

Bhagawati-Prasad VN, De Leenheer E, Keefe NP, Ryan LA, Carlring J, Heath AW.

J Immune Based Ther Vaccines. 2010 Feb 4;8:1. doi: 10.1186/1476-8518-8-1.


B-cell-T-cell activation and interaction in common variable immunodeficiency.

Rezaei N, Wing JB, Aghamohammadi A, Carlring J, Lees A, Asgarian-Omran H, Pourpak Z, Sarrafnejad A, Kardar GA, Shahrestani T, Masoumi F, Zare A, Saghafi S, Sarrafzadeh S, Foster RA, Heath AW, Read RC.

Hum Immunol. 2010 Apr;71(4):355-62. doi: 10.1016/j.humimm.2010.01.019. Epub 2010 Feb 19.


Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.

Foster RA, Carlring J, McKendrick MW, Lees A, Borrow R, Read RC, Heath AW.

Clin Vaccine Immunol. 2009 May;16(5):692-8. doi: 10.1128/CVI.00485-08. Epub 2009 Mar 11.


Antibodies against cell surface antigens as very potent immunological adjuvants.

Barr T, Carlring J, Hatzifoti C, Heath AW.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-20-1.


Co-stimulatory agonists as immunological adjuvants.

Barr TA, Carlring J, Heath AW.

Vaccine. 2006 Apr 24;24(17):3399-407. Epub 2006 Feb 24. Review.


CD40 antibody as an adjuvant induces enhanced T cell responses.

Carlring J, Barr TA, McCormick AL, Heath AW.

Vaccine. 2004 Sep 3;22(25-26):3323-8.


A potent adjuvant effect of CD40 antibody attached to antigen.

Barr TA, McCormick AL, Carlring J, Heath AW.

Immunology. 2003 May;109(1):87-92.


Supplemental Content

Loading ...
Support Center